Maharashtra FDA Cancels 10 Ayurvedic Drug Licenses After Statewide Quality Inspections
The Maharashtra Food and Drug Administration (FDA) conducted a statewide inspection of 434 Ayurvedic drug manufacturers, uncovering serious violations of manufacturing and quality-control standards. As a result, 135 manufacturers received show-cause notices, and 10 had their licenses permanently cancelled due to major breaches that could impact medicine safety and public health. Violations included lack of qualified technical staff, non-functional quality-control departments, unhygienic premises, and improper record-keeping. The FDA aims to enforce compliance with the Drugs and Cosmetics Act and Good Manufacturing Practices to ensure medicine quality.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (50/100). Lens Score 63/100.
Outlets measured: freepressjournal, economictimes. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (48–52/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
economictimes broke this story on 12 Aug, 03:42 am. Other outlets followed.